P
Peter G. Gibson
Researcher at University of Newcastle
Publications - 774
Citations - 53254
Peter G. Gibson is an academic researcher from University of Newcastle. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 103, co-authored 711 publications receiving 45722 citations. Previous affiliations of Peter G. Gibson include University of Sydney & National Health and Medical Research Council.
Papers
More filters
Journal ArticleDOI
Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes.
Laura Cordova-Rivera,Laura Cordova-Rivera,Peter G. Gibson,Paula Gardiner,Sarah A. Hiles,Sarah A. Hiles,Vanessa M. McDonald +6 more
TL;DR: In severe asthma and bronchiectasis, extrapulmonary features including physical activity and leg strength have a significant impact on HRQoL, especially within the activity and impact domains.
Journal ArticleDOI
Speech Pathology Intervention for Chronic Refractory Cough: A Pilot Study Examining the Benefit of Using Prerecorded Videos as an Adjunct to Therapy.
TL;DR: The addition of supplemental pre-recorded videos of SPI for CRC did not lead to greater accuracy of therapy exercise practice or superior treatment outcomes than standard SPI alone.
Journal ArticleDOI
Treatable Traits in Elderly Asthmatics from the Australasian Severe Asthma Network: A Prospective Cohort Study.
Wen Wen Wu,Xin Zhang,Li Min,Ying Liu,Zhi Hong Chen,Min Xie,Shu Zhen Zhao,Gang Wang,Hong Ping Zhang,Ting Wang,Ling Qin,Lei Wang,Brian G. Oliver,Brian G. Oliver,Hua Jing Wan,Jie Zhang,Vanessa M. McDonald,Guy B. Marks,Weimin Li,Surinder S. Birring,Peter G. Gibson +20 more
TL;DR: Wang et al. as discussed by the authors evaluated the association of treatable traits (TTs) with future exacerbations, and developed an exacerbation prediction model based on TTs and asthma control levels, and the overall performance was externally validated in an independent cohort.
Journal ArticleDOI
Obesity in COPD: to treat or not to treat?
TL;DR: This poster presents a poster presented at the annual meeting of the Australian Academy of Breathing and Sleep Medicine and Public Health Sciences (AAPS) to discuss the future direction of research in this area.
Journal ArticleDOI
Rosuvastatin, lycopene and omega-3 fatty acids: a potential treatment for systemic inflammation in COPD; a pilot study
TL;DR: This study shows that rosuvastatin, omega-3 fatty acids and lycopene have some anti-inflammatory effects systemically, but rosuVastatin may increase airway neutrophils, which would be undesirable in COPD patients, warranting further investigation.